Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations
K Korfi, S Ali, J Heward and J Fitzgibbon are supported by Cancer Research UK Programme Grant
[C15966/A15968] and Bloodwise Programme Grant . S Ali is also a recipient of Cancer
Research UK Clinical Careers Committee research bursary [C56515/A21397]
Epigenetic mutations, epigenetic therapies, EZH2 inhibitors, follicular lymphoma, HDAC inhibitors
Publisher: 'Informa UK Limited'
DOI identifier: 10.1080/15592294.2017.1282587